Similarly, PD-L1 expression is reported to be significantly higher in TNBC cancers compared to non-TNBC cancers (45), and MDA-231 breast cancer cells have been shown to release EVs carrying PD-L1. This evidence concerns the gene CD274 and breast cancer.